Cargando…
Leaving the lysosome behind: novel developments in autophagy inhibition
The search for a single silver bullet for the treatment of cancer has now been overshadowed by the identification of multiple therapeutic targets unique to each malignancy and even to each patient. In recent years, autophagy has emerged as one such therapeutic target. In response to both therapeutic...
Autores principales: | Solitro, Abigail R, MacKeigan, Jeffrey P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Science Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886745/ https://www.ncbi.nlm.nih.gov/pubmed/26689099 http://dx.doi.org/10.4155/fmc.15.166 |
Ejemplares similares
-
A Potent and Selective ULK1 Inhibitor Suppresses Autophagy and Sensitizes Cancer Cells to Nutrient Stress
por: Martin, Katie R., et al.
Publicado: (2018) -
Computational Analysis of an Autophagy/Translation Switch Based on Mutual Inhibition of MTORC1 and ULK1
por: Szymańska, Paulina, et al.
Publicado: (2015) -
Identification of Kinases Responsible for p53-Dependent Autophagy
por: Celano, Stephanie L., et al.
Publicado: (2019) -
Mitochondria in cancer: at the crossroads of life and death
por: Fogg, Vanessa C., et al.
Publicado: (2011) -
Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib
por: Goodall, Megan L, et al.
Publicado: (2014)